Verona Pharma PLC Holding(s) in Company (3916G)
August 05 2016 - 4:27AM
UK Regulatory
TIDMVRP TIDMAV.
RNS Number : 3916G
Verona Pharma PLC
05 August 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or Verona Pharma plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------------- --------------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
---------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
-------------------------------------------------------------------------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
-------------------------------------------------------------------------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
-------------------------------------------------------------------------------------------------------------
An event changing the breakdown of voting rights
-------------------------------------------------------------------------------------------------------------
Other (please CHANGE TO THE NUMBER OF VOTING RIGHTS
specify): IN ISSUE, FOLLOWING THE RECENT PLACING
----------------------------------------------------------- ------------------------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
(iii)
------------------------------------------------------------- ------------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):(iv)
BNY Norwich Union Nominees
Limited 4,565,531*
Chase (GA Group) Nominees
Limited 117,026,513*
State Street Nominees Limited
21,997,411*
Available on request 124,125*
*denotes direct interest
Chase (GA Group) Nominees
Limited 14,755,004
Chase Nominees Limited 3,872,597
Vidacos Nominees Limited 18,701,411
------------------------------------------------------------- ------------------------------------------------
5. Date of the transaction 3 August 2016
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------------- ------------------------------------------------
6. Date on which issuer 4 August 2016
notified:
------------------------------------------------------------- ------------------------------------------------
7. Threshold(s) that is/are 14% to 5% Change at Direct
crossed or Interest Level and 17% to
reached: (vi, vii) 7% Change at Combined Interest
Level
------------------------------------------------------------- ------------------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
---------------- ------------------------------ ------------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights (x)
Shares Voting
Rights
---------------- ---------------- ------------ ------------- ------------------------- ------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
---------------- ---------------- ------------ ------------- ------------ ----------- ------- ---------
Ordinary
Shares
GB00B06GSH43 181,781,279 181,781,279 181,042,592 143,713,580 37,329,012 5.60% 1.46%
---------------- ------------ ------------- ------------ ----------- ------- ---------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
---------------- ---------------- --------------------------- ------------------------- ------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
181,042,592 7.06%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-----------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited and Friends Provident
International Limited, with the following chain of controlled
undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Friends Provident International Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Life Holdings UK Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Friends Life FPG Limited (wholly owned subsidiary of
Aviva Life Holdings UK Limited)
* Friends Life FPL Limited (wholly owned subsidiary of
Friends Life FPG Limited)
* Friends Life Limited (wholly owned subsidiary of
Friends Life FPL Limited)
* Friends Life and Pensions Limited (wholly owned
subsidiary of Friends Life Limited)
* Friends Provident International Limited (wholly owned
subsidiary of Friends Life and Pensions Limited)
Proxy Voting:
-----------------------------------------------------------------
10. Name of the proxy holder: See Section 4
---------------------------------------------- -----------------
11. Number of voting rights proxy
holder will cease
to hold:
---------------------------------------------- -----------------
12. Date on which proxy holder will
cease to hold
voting rights:
---------------------------------------------- -----------------
Figures are based on a total
13. Additional information: number of voting rights of
2,565,719,826, as per the
Company's Admission of Placing
Shares, Total Voting Rights,
Directors' Holding, Warrant
Shares and Block Listing
Announcement of 29 July 2016.
------------------------------- --------------------------------
14. Contact name: James Clark, Aviva plc
------------------------------- --------------------------------
15. Contact telephone number: 01603 683853
------------------------------- --------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUGUWPRUPQURA
(END) Dow Jones Newswires
August 05, 2016 04:27 ET (08:27 GMT)
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jul 2023 to Jul 2024
